In clinical trials, the safety profile of clevidipine was generally similar to sodium nitroprusside, nitroglycerin, or nicardipine in patients undergoing cardiac surgery.
For over 130 years, nitroglycerin has been used medically as a potent vasodilator to treat heart conditions, such as angina pectoris and chronic heart failure.